ESCMID
CMI
EUCAST Newsletter
EUCAST News
Search
Back
Close
About EUCAST
About EUCAST
Overview
Close
Organisation
Overview
Steering Committee
General Committee
EUCAST Statutes
National AST Committees (NAC)
Network Laboratories
Development Laboratories (EDL)
View all
Subcommittees
Overview
Antimycobacterial Susceptibility Testing (AMST)
Antifungal Susceptibility Testing (AFST)
Veterinary Subcommittee on Antimicrobial Susceptibility Testing (VetCAST)
Phage Susceptibility Testing Subcommittee (PST)
Subcommittee on WGS and Phenotypic AST
View all
Meetings
Overview
Steering Committee Meetings
General Committee Meetings
Public Consultations
Overview
SOPs
Overview
IVDR and EUCAST
Overview
News
Overview
Publications and Presentations
Overview
Bacteria
Bacteria
Overview
Close
Clinical Breakpoints and Interpretation
Overview
Clinical Breakpoint Tables
Definition of S, I and R
When there are no breakpoints?
Breakpoints in Brackets
Guidance Documents
Overview
Important Additional Information
Overview
Expert Rules
Expected Phenotypes
Resistance Detection
MIC and Zone Distributions, ECOFFs
Overview
Methodology and Instructions
Overview
Disk Diffusion and Quality Control
MIC Determination
Warnings
Media Preparation
Disk Diffusion Implementation
EUCAST Panels of Phenotypically Defined Strains
Overview
EUCAST Panel of S. pneumoniae and betalactam agents
EUCAST Panel of nine well characterized P. aeruginosa strains
IVDR and EUCAST
View all
Rapid AST in blood culture
Overview
Rapid AST directly from blood culture bottles
Methods and Quality Control
Breakpoints for Rapid AST
Resistance Detection in RAST
RAST FAQ
RAST MIC:zone diameter correlations
RAST Publications
View all
Development of Clinical Breakpoints and ECOFFs
Overview
About Clinical Breakpoints
Setting Breakpoints
Public Consultations
Rationale Documents
MIC:Zone Diameter correlations
Technical Notes on Antibacterial Agents
View all
FAQ and EDL Services
Overview
FAQ
EDL MIC Testing Services
Mycobacteria (AMST)
Mycobacteria (AMST)
Overview
Close
Subcommittee
Overview
Clinical Breakpoints and Interpretation
Overview
MIC distributions and ECOFFs
Overview
Development of Clinical Breakpoints and ECOFFs
Overview
Public Consultations
Rationale Documents
Methodology and Instructions
Overview
Reference Method
Mycobacteria FAQ
Warnings
IVDR and EUCAST
Publications and Presentations
Overview
Fungi (AFST)
Fungi (AFST)
Overview
Close
Subcommittee
Overview
Clinical Breakpoints and Interpretation
Overview
Clinical breakpoint table
When there are no antifungal breakpoints
Development of clinical breakpoints and ECOFFs
Overview
Rationale documents
Public consultations
Methodology and Instructions
Overview
AST of Yeasts
AST of Moulds
AST of Dermatophytes
Warnings
Quality Control
IVDR and EUCAST
View all
Publications and Presentations
Overview
Technical Notes on Antifungal Agents
VetCAST
VetCAST
Overview
Close
Subcommittee
Overview
MIC distributions and ECOFFs
Overview
Development of clinical breakpoints and ECOFFs
Overview
Rationale Documents
Publications and presentations
Overview
Industry
Industry
Overview
Close
Education
Education
Overview
Close
Search
ESCMID
CMI
EUCAST Newsletter
EUCAST News
Close
Search
Frequent searches
breakpoints
rationale documents
expected phenotypes
public consultation
endocarditis pathogens
guidance documents
Suggestions
Close
Search
Search Results
Search
No results found for
“”
